Innate Pharma S.A. IPH.PA
Set alert
1.22 EUR -0.04 -2.87%
As of Nov 2, 11:35 AM ET
1.22 Day range 1.26
1.03 52-week range 2.33
- YTD
- -23.75%
- 1 year
- -26.95%
- Open
- 1.26
- Prev close
- 1.26
- Mkt cap
- 136.27M
- Vol
- 170.34K
- Avg vol
- 452.87K
- EPS
- -0.51
- P/E
- 0.00
More statistics
- Low
- 1.22
- High
- 1.26
1Y chart
Signals (45)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 15, 2026 | 2 weeks ago |
| RSI: Oversold | Sep 25, 2026 | 1 month ago |
| SMA: Bearish | Sep 24, 2026 | 1 month ago |
| SMA: Bearish | Sep 9, 2026 | 1 month ago |
| MACD: Sell Signal | Aug 26, 2026 | 2 months ago |
| SMA: Bullish | Aug 10, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 10, 2026 | 2 months ago |
| RSI: Overbought | Aug 10, 2026 | 2 months ago |
| MACD: Sell Signal | Jul 30, 2026 | 3 months ago |
| SMA: Bearish | Jul 29, 2026 | 3 months ago |
| SMA: Bullish | Jul 27, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 27, 2026 | 3 months ago |
| SMA: Bullish | Jul 21, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 8, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 6, 2026 | 3 months ago |
| MACD: Sell Signal | Jun 25, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 23, 2026 | 4 months ago |
| SMA: Bullish | May 29, 2026 | 5 months ago |
| MACD: Sell Signal | May 27, 2026 | 5 months ago |
| SMA: Bearish | May 26, 2026 | 5 months ago |
| SMA: Bullish | May 14, 2026 | 5 months ago |
| RSI: Overbought | May 14, 2026 | 5 months ago |
| SMA: Bullish | May 6, 2026 | 6 months ago |
| MACD: Buy Signal | May 4, 2026 | 6 months ago |
| MACD: Sell Signal | Apr 24, 2026 | 6 months ago |
| SMA: Bullish | Apr 14, 2026 | 6 months ago |
| MACD: Buy Signal | Apr 2, 2026 | 7 months ago |
| RSI: Oversold | Mar 13, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 4, 2026 | 8 months ago |
| MACD: Buy Signal | Feb 24, 2026 | 8 months ago |
| MACD: Sell Signal | Feb 20, 2026 | 8 months ago |
| MACD: Buy Signal | Feb 18, 2026 | 8 months ago |
| MACD: Sell Signal | Feb 6, 2026 | 8 months ago |
| MACD: Buy Signal | Jan 22, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 8, 2026 | 9 months ago |
| MACD: Buy Signal | Dec 31, 2025 | 10 months ago |
| MACD: Sell Signal | Dec 12, 2025 | 10 months ago |
| MACD: Buy Signal | Dec 11, 2025 | 10 months ago |
| MACD: Sell Signal | Dec 10, 2025 | 10 months ago |
| SMA: Bullish | Nov 27, 2025 | 11 months ago |
| MACD: Buy Signal | Nov 24, 2025 | 11 months ago |
| SMA: Bearish | Nov 11, 2025 | 11 months ago |
| SMA: Bearish | Nov 11, 2025 | 11 months ago |
| SMA: Bullish | Nov 10, 2025 | 11 months ago |
| SMA: Bullish | Nov 10, 2025 | 11 months ago |
Compare IPH.PA
Chart and line up IPH.PA against other symbols or a saved comparison set.
- IPH.PA Innate Pharma S.A.
1.22
-0.04 -2.87%
- SPY State Street SPDR S&P 500 ETF Trust
752.91
-2.81 -0.37%
- QQQ Invesco QQQ Trust
681.95
-8.54 -1.24%
Sign in to keep these symbols in a saved comparison set.
| Metric | IPH.PA | SPY | QQQ |
|---|---|---|---|
| Last price | 1.22 | 752.91 | 681.95 |
| Change | -0.036 | -2.81 | -8.54 |
| Change % | -2.87% | -0.371831% | -1.24% |
| Open | 1.26 | 759.45 | 695.32 |
| Day high | 1.26 | 763.86 | 699.43 |
| Day low | 1.22 | 751.90 | 680.36 |
| Previous close | 1.26 | 755.72 | 690.49 |
| Volume | 170.34K | 37.79M | 47.56M |
| Average volume | 452.87K | 41.46M | 35.11M |
| Market cap | 136.27M | 799.01B | 463.83B |
| P/E ratio | 0.00 | 23.90 | 26.11 |
| Earnings per share | -0.51 | 31.50 | 26.12 |
| Dividend yield | — | 0.99 | 0.43 |
| 52-week high | 2.33 | 781.62 | 762.86 |
| 52-week low | 1.03 | 629.28 | 555.60 |
| 1-week return | -6.15% | -1.63% | -4.25% |
| 1-month return | -7.58% | -2.17% | -9.02% |
| 3-month return | -20.26% | +0.787117% | -0.87792% |
| 6-month return | +1.67% | +4.48% | +1.16% |
| Year-to-date return | -23.75% | +10.41% | +11.01% |
| 1-year return | -26.95% | +10.39% | +8.41% |
| 2-year return | -26.95% | +32.13% | +40.32% |
| 50-day moving average | 1.49 | 767.49 | 725.00 |
| 200-day moving average | 1.48 | 728.85 | 679.52 |
| Target price | — | — | — |
| Beta | — | 1.00 | 1.22 |
| Short ratio | — | — | — |
| Institutional ownership | — | — | — |